New Immunotherapy Makes Unresectable Eye Cancer Treatable

0 Views

07/05/23

The U.S. Food and Drug Administration approved a new drug to treat unresectable metastatic uveal melanoma, which is the most common eye cancer in adults. There has been no effective treatment for it; many patients who developed metastatic disease usually die within one year. Watch this video to learn more about the disease and new treatment.

Thanks for watching!

If you would like to make a suggestion for our next 'Making Sense of Science' video, you can submit one here: https://www.nfcr.org/making-se....nse-of-science-nfcr-

For more cancer information, please visit nfcr.org.

To make a gift to support cancer research, visit nfcr.org/donate.